PT - JOURNAL ARTICLE AU - Farber, Paulo L. AU - Dias, Ana AU - Freitas, Teresa AU - Pinho, Ana C. AU - Viggiano, Diego AU - Saldanha, Carlota AU - Silva-Herdade, Ana S. TI - Evaluation of Hemorheological Parameters as Biomarkers of Calcium Metabolism and Insulin Resistance in Postmenopausal Women AID - 10.1101/2020.11.13.20231050 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.13.20231050 4099 - http://medrxiv.org/content/early/2020/11/16/2020.11.13.20231050.short 4100 - http://medrxiv.org/content/early/2020/11/16/2020.11.13.20231050.full AB - BACKGROUND Calcium, vitamin D and insulin resistance are linked to osteoporosis and cardiovascular disease in menopause.OBJECTIVE Determine if hemorheological parameters related to blood viscosity in microcirculation are linked to calcium metabolism and insulin resistance in menopause.METHODS 25-Hydroxyvitamin D (25(OH)D)), 1,25-dihydroxyvitamin D3 (1,25(OH)2D), Parathyroid Hormone, ionized calcium, Glucose, Insulin and Hemoglobin A1c were measured in blood from 43 volunteers. Red blood cells (RBC) aggregation, RBC deformability and Whole Blood Viscosity were also performed.RESULTS 25(OH)D showed a positive correlation with RBC deformability 0.60 Pa. Subjects with 25(OH)D ≤ 29.00 ng/mL had lower RBC deformability 0.60 Pa. and higher RBC Aggregation and higher HOMA-IR. Ionized calcium showed a negative correlation with RBC Aggregation. Subjects with ionized calcium ≤1.24 mmol/L showed higher RBC Aggregation. There was a positive correlation between HOMA-IR and RBC Aggregation and HOMA-IR showed a negative correlation with RBC deformability 0.30 Pa. Subjects with HOMA-IR<1.80 showed lower RBC aggregation and higher RBC deformability at 0.30 Pa, 0.60 Pa, 1.20 Pa, 3.0 Pa and 6.0 Pa.CONCLUSION Low 25(OH)D, low ionized calcium and high HOMA-IR are related to impaired hemorheology in menopause. RBC aggregation and deformability can be used as biomarkers of calcium metabolism and insulin resistance in menopause.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by Hospital da Luz de Aveiro and Fundacao para a Ciencia e Tecnologia: LISBOA-01-0145-FEDER-007391, project cofunded by FEDER, through POR Lisboa 2020 - Programa Operacional Regional de Lisboa, Portugal 2020.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local Ethical Committee of Hospital da Luz de Aveiro and authorized by Research Committee of Hospital da Luz. All volunteers had written explanation about the study and procedures and signed the informed consent. All personal data were protected accordingly with European General Data Protection Regulation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.